Your browser doesn't support javascript.
loading
Dengzhanxixin Injection Ameliorates Cognitive Impairment Through a Neuroprotective Mechanism Based on Mitochondrial Preservation in Patients With Acute Ischemic Stroke.
An, Haiting; Tao, Wuhai; Liang, Ying; Li, Peng; Li, Min; Zhang, Xiaxia; Chen, Kewei; Wei, Dongfeng; Xie, Daojun; Zhang, Zhanjun.
Affiliation
  • An H; State Key Laboratory of Cognitive Neuroscience and Learning & IDG/McGovern Institute for Brain Research, Beijing Normal University, Beijing, China.
  • Tao W; BABRI Centre, Beijing Normal University, Beijing, China.
  • Liang Y; Center for Brain Disorders and Cognitive Sciences, Shenzhen University, Shenzhen, China.
  • Li P; School of Biomedical Engineering, Capital Medical University, Beijing, China.
  • Li M; Institute of Basic Medicine Research, Xi Yuan Hospital affiliated to China Academy of Chinese Medical Sciences, Beijing, China.
  • Zhang X; State Key Laboratory of Cognitive Neuroscience and Learning & IDG/McGovern Institute for Brain Research, Beijing Normal University, Beijing, China.
  • Chen K; BABRI Centre, Beijing Normal University, Beijing, China.
  • Wei D; State Key Laboratory of Cognitive Neuroscience and Learning & IDG/McGovern Institute for Brain Research, Beijing Normal University, Beijing, China.
  • Xie D; BABRI Centre, Beijing Normal University, Beijing, China.
  • Zhang Z; Banner Good Samaritan PET Center, Banner Alzheimer's Institute, Phoenix, AZ, United States.
Front Pharmacol ; 12: 712436, 2021.
Article in En | MEDLINE | ID: mdl-34526899

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Front Pharmacol Year: 2021 Document type: Article Affiliation country: China Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Front Pharmacol Year: 2021 Document type: Article Affiliation country: China Country of publication: Switzerland